Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel
about
Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseasesATP-binding cassette (ABC) transporters in normal and pathological lungPaclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation TherapyMultidrug Resistance Proteins (MRPs) and Cancer TherapyMicrotubule-binding agents: a dynamic field of cancer therapeutics.bba, a synthetic derivative of 23-hydroxybutulinic acid, reverses multidrug resistance by inhibiting the efflux activity of MRP7 (ABCC10)Targeting multidrug resistance in cancerImatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10).Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs.Xenobiotic, bile acid, and cholesterol transporters: function and regulation.Taccalonolides: Novel microtubule stabilizers with clinical potential.Abcc10 status affects mammary tumour growth, metastasis, and docetaxel treatment responseStructure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters.Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar.Characterization of zebrafish Abcc4 as an efflux transporter of organochlorine pesticides.Synthesis and biological evaluation of pentacyclic strychnos alkaloids as selective modulators of the ABCC10 (MRP7) efflux pumpA Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer CellsContribution of Abcc10 (Mrp7) to in vivo paclitaxel resistance as assessed in Abcc10(-/-) mice.Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunctionDiscovery of regulatory elements in human ATP-binding cassette transporters through expression quantitative trait mapping.Contribution of tumoral and host solute carriers to clinical drug response.PDE5 inhibitors, sildenafil and vardenafil, reverse multidrug resistance by inhibiting the efflux function of multidrug resistance protein 7 (ATP-binding Cassette C10) transporterFunction and regulation of multidrug resistance proteins (MRPs) in the renal elimination of organic anions.Docetaxel in ovarian cancer.Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft modelsImpact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors.Modulation of the ATPase and transport activities of broad-acting multidrug resistance factor ABCC10 (MRP7).Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins.Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDSPharmacology, pharmacokinetics and pharmacogenomics of paclitaxel.Drug transport across the placenta, role of the ABC drug efflux transporters.Resistance to chemotherapy in cancer: a complex and integrated cellular response.The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms.Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B.Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma.Multidrug resistance associated proteins in multidrug resistance.Amonafide: a future in treatment of resistant and secondary acute myeloid leukemia?Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance.Enriched variations in TEKT4 and breast cancer resistance to paclitaxel.Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines.
P2860
Q24601963-3ED97B80-181C-4997-9F43-4ACFA2B327F8Q24811895-D25A05DA-4153-4E46-BBF4-010A34EFFBBCQ26775004-0E636191-769B-4004-BEC0-7BADD4F91672Q26992204-4B00F5B5-8E87-4911-82B6-3ADFE9F99127Q27690249-2CC653AB-E214-485B-A865-222EAD8A1EB1Q28533538-3546867C-289D-477C-8E75-0705F90DCA42Q29616803-985B4EB6-5731-40C1-AE44-D805F16C0E16Q33511437-FBA11273-6A8F-44C5-82EB-213B3C601264Q33633267-C5BEA83B-8AC1-4EB4-A39F-099A986D64EEQ33714593-C09ED1BB-3828-4706-972B-6B66C0C31AADQ33759235-CF0182E2-BECA-4E32-8FF6-C17DAACAF44CQ34051930-C51E0C2B-B7AA-4B9A-AD3A-30FE25E5389EQ34568808-9A78CFE8-0FAD-4057-BAAA-8EB8B70F5DCBQ34581006-0B57B79B-53AB-44ED-9618-5E19FBE33159Q34639515-402FC3E2-E2CC-472C-BEA1-13208CE338B4Q34796487-B676515B-13F3-4D23-9F86-803894D31D80Q34972581-A456E957-538C-4E2A-BC99-7CE0255EF557Q34988593-E411F1AA-5E14-49C6-A301-626FDDBE2118Q35016654-5CAA0809-ADED-467B-AA14-F30C80057806Q35886142-2C53CFE5-A872-4DA3-A2FD-4A5543DE9822Q35946876-B18B722D-DCAA-44C5-85F0-D917145F3F09Q36124056-CC708591-615A-4A22-88C9-0CA034D02178Q36300799-B926D6D5-86EE-461E-B278-0E636D6D479AQ36326263-40E15B5F-0C37-4418-A479-40E98BB5DD0EQ36442931-3BF58375-A391-4755-8BAA-D38F2BEAF900Q36456104-452F2D18-06E4-4246-8465-78933100E418Q36476289-F29D1EB1-334D-47ED-B243-D1A29CA7690CQ36525551-768B8205-41BF-4518-9B93-82C0AFC157AFQ36708715-DC7E6056-1E10-4A72-904A-5E6C66835DD3Q36885663-913271B5-B724-4386-A17F-A31EA36C5F4CQ37008886-13BEB6A6-C3F9-43DD-915C-93A1AFBC6DA2Q37079652-BB7F90B0-DFBB-4ED9-A400-D99CC61FA4B2Q37306809-5FEF9921-88F4-401A-9AC2-A8917AC77C74Q37351193-3BE88683-2DDE-46D6-B6D1-68E3BA9BDFA0Q37634419-AA3136E0-2125-460A-BE1E-F13CD3B1FF68Q37958163-CFA72C33-AA5A-43E1-A8CF-BFB710C8A2AEQ37978341-67E46C35-B74C-4CDF-B9A1-2CF16BAE0CEAQ38246305-B42DCC6E-2D67-41C7-AC6D-B984F89E6DC6Q38995526-E13DF059-B35B-4992-931C-6999C1B385F1Q39090000-E3B593A7-AF92-4703-9254-48872D393FD0
P2860
Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Analysis of the drug resistanc ...... CC10): resistance to docetaxel
@ast
Analysis of the drug resistanc ...... CC10): resistance to docetaxel
@en
Analysis of the drug resistanc ...... CC10): resistance to docetaxel
@nl
type
label
Analysis of the drug resistanc ...... CC10): resistance to docetaxel
@ast
Analysis of the drug resistanc ...... CC10): resistance to docetaxel
@en
Analysis of the drug resistanc ...... CC10): resistance to docetaxel
@nl
prefLabel
Analysis of the drug resistanc ...... CC10): resistance to docetaxel
@ast
Analysis of the drug resistanc ...... CC10): resistance to docetaxel
@en
Analysis of the drug resistanc ...... CC10): resistance to docetaxel
@nl
P2093
P1433
P1476
Analysis of the drug resistanc ...... CC10): resistance to docetaxel
@en
P2093
Elizabeth Hopper-Borge
Gary D Kruh
Irina Shchaveleva
Martin G Belinsky
Zhe-Sheng Chen
P304
P356
10.1158/0008-5472.CAN-03-3111
P407
P577
2004-07-15T00:00:00Z